Suitability of enalapril as a probe of the dipeptide transporter system: In vitro and in vivo studies

Pharmaceutical Research

Volumn 13, Issue 7, 1996, Pages 1078-1082

  Morrison, Richard A ^a   Chong, Saeho ^a   Marino, Anthony M ^a   Wasserman, Martin A ^b   Timmins, Peter ^c   Moore, Vanessa A ^d   Irwin, William J ^d  

^a BRISTOL MYERS SQUIBB   (United States)

^b SANOFI   (France)

^c BMS PRI   (United Kingdom)

^d ASTON UNIVERSITY   (United Kingdom)

Author keywords

Absorption; Caco 2; Dogs; Enalapril; rats

Indexed keywords

AMOXICILLIN; BETA LACTAM ANTIBIOTIC; CEFACLOR; CEFALEXIN; CEFAZOLIN; CEFOXITIN; CEFRADINE; CERANAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; GLYCYLPROLINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; COLON ADENOCARCINOMA; DIFFUSION; DOG; DRUG ABSORPTION; DRUG UPTAKE; INTESTINE ABSORPTION; INTESTINE MUCOSA PERMEABILITY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BIOLOGICAL TRANSPORT; CACO-2 CELLS; CEFACLOR; DIPEPTIDES; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENALAPRIL; HUMANS; INTESTINAL ABSORPTION; JEJUNUM; MALE; MODELS, BIOLOGICAL; ORGANOPHOSPHORUS COMPOUNDS; PERMEABILITY; PROLINE; RATS;

EID: 0029781995     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016071027177     Document Type: Article

References (17)

1. D. I. Friedman and G. L. Amidon. Passive and carrier-mediated intestinal absorption components of two angiotensin converting enzyme (ACE) inhibitor prodrugs in rats: enalapril and fosinopril. Pharm. Res. 6:1043-1047 (1989).
2. H. Yuasa, G. L. Amidon, and D. Fleisher. Noncompetitive inhibition of intestinal cephradine uptake by enalapril: An enalapril specific inhibitory binding site on the peptide carrier, Pharm. Res. 8:(10), S-221 (1991).
3. S. Yee, and G. L. Amidon. Transport characterization of the ACE inhibitor enalapril in rabbit intestinal brush border membrane vesicles, Pharm. Res. 8:(10), S-198 (1991).
4. D. T. Thwaites, M. Cavet, B. H. Hirst, and N. Simmons. Angiotensin-converting enzyme (ACE) inhibitor transport in human intestinal epithelial (Caco-2) cells, Brit. J. Pharmacol. 114:981-986 (1995).
5. A. M. Marino, S. Chong, S. A. Dando, K. J. Kripalani, M. S. Bathala, and R. A. Morrison. Distribution of the dipeptide transporter system along the gastrointestinal tract of rats based on absorption of a stable and specific probe, SQ-29852, J. Pharm. Sci. 85:282-286 (1996).
6. V. A. Moore, S. Chong, S. A. Dando, W. Lau, W. J. Irwin, P. Timmins, and R. A. Morrison. Systematic evaluation of the structural requirements for the intestinal dipeptide transporter system, Pharm. Res. 12:(9) (suppl), S-301 (1995).
7. A. H. Dantzig and L. Bergin. Uptake of the cephalosporin, cephalexin, by a dipeptide transport carrier in the human intestinal cell line, Caco2, Biochemica et Biophysica Acta 1027:211-217 (1990).
8. A. H. Dantzig, D. C. Duckworth, and L. B. Tabas. Transport mechanism responsible for the absorption of loracarbef, cefixime, and cefuroxime axetil into human intestinal Caco-2 cells, Biochim. Biophys. Acta. 1191:7-13 (1994).
9. D. I. Friedman and G. L. Amidon, Intestinal absorption mechanism of dipeptide angiotensin converting enzyme inhibitors of the lysyl-proline type: lisinopril and SQ 29,852, J. Pharm. Sci. 78:995-998 (1989).
10. M. Hu, J. Chen, Y. Zhu, A. H. Dantzig, R. E. Stratford, and M. T. Kuhfeld. Mechanism and kinetics of transcellular transport of a new beta-lactam antibiotic across an intestinal epithelial membrane model system (Caco-2), Pharm. Res. 11:(10), 1405-13 (1994).
11. P. L. Nicklin, W. J. Irwin, and P. Timmins. Uptake and transport of an ACE-inhibitor (SQ-29852) by Caco-2 cells, J. Pharm. Pharmacol. 44:1091 (1992).
12. M. S. Bathala, S. J. Lan, A. V. Dean, K. J. Kripalani, and S. H. Weinstein. Disposition of SQ-29852 in dogs, Pharm. Res. 6:(suppl.) S-282, (1989).
13. L. Moore, P. Kramer, J. Foley, J. Tu, B. Swanson, and K. Duchin. Ascending multiple-dose study of a new ACE inhibitor, Abstract presented at the ASCPT meeting, San Diego, CA, March 9-11, 1989.
14. M. Sugawara, H. Saitoh, K. Iseki, K. Miyazaki, and T. Arita. Contribution of passive and transport mechanisms to the intestinal absorption of β-lactam antibiotics, J. Pharm. Pharmacol. 42:314-318 (1989).
15. B. H. Stewart, S. A. Dando, and R. A. Morrison. In vitro uptake of SQ-29852 by everted rat intestinal rings, Pharm. Res. 7:(9) (suppl), S-156 (1990).
16. S. Chong, S. A. Dando, and R. A. Morrison. In vitro permeability through Caco-2 cells is not quantitatively predictive of in vivo absorption for drugs absorbed via the dipeptide transporter system, Pharm. Res. 13:(1), (1996).
17. K. Tamura, P. K. Bhatnagar, J. S. Takata, C.-P. Lee, P. L. Smith, and R. T. Borchardt. Inhibition of uptake by the oligopeptide transporter does not correlate with transepithelial transport, Pharm. Res. 12:(9) (suppl), S-302 (1995).